Linked e-resources
Details
Table of Contents
Ch 1: Present and future of urinary stents
Ch 2: Indications, Complications and side effects of Ureteral stents
Ch 3: Indications, Complications and side effects of metallic ureteral stents
Ch 4: Urethral stents. Indications, complications and adverse effects
Ch 5: Ureteral stents. Impact on patient's quality of life.
Ch 6: Strategies to improve the quality of life of stented patients
Ch 7: Use of drugs to reduce the morbidity of ureteral stents
Ch 8: Ureteral stent designs to reduce stent-related symptoms and improve patient quality of life
Ch 9: Encrustation in urinary stents
Ch 10: Forgotten ureteral stent syndrome
Ch 11: Endourological management of encrusted ureteral stents
Ch 12: Pediatric Ureteral Stents
Ch 13: Flow dynamics in stented ureter
Ch 14: Methodology for the development and validation of new stent designs: in vitro and in vivo models
Ch 15: Methodology on clinical evaluation of urinary stents
Ch 16: A Dynamically Degradable Surface: Can We ‘Fool’ Bacteria to Delay Biofouling in Urinary Stents?
Ch 17: Biomaterials for ureteral stents: advances and future perspectives
Ch 18: Coatings for urinary stents:current state and future directions
Ch 19: Bacterial adhesion and biofilm formation: hydrodynamics effects
Ch 20: Biomaterial-associated infection: pathogenesis and prevention
Ch 21: Antibiotic-free solutions for the development of biofilm prevention coatings
Ch 22: Plasma Based Approaches for Deposition And Grafting Of Antimicrobial Agents To Polymer Surfaces
Ch 23: Antimicrobial biosurfactants towards the inhibition of biofilm formation
Ch 24: Novel antimicrobial strategies to combat biomaterial infections
Ch 25: Light-activated polymer nanocomposites doped with a new type of carbon quantum dots for antibacterial applications
Ch 26: Nanoparticles. Potential for use to prevent infections
Ch 27: Urinary tract infections and encrustation in urinary stents
Ch 28: Learning from our mistakes:Applying Vascular Stent Technologies to the Urinary Tract
Ch 29: Biodegradable urinary stents
Ch 30: New double-J stent design for preventing/reducing irritative bladder symptoms & flank pain
Ch 31: Drug eluting devices in the urinary tract
Ch 32: Methods and Materials for drug eluting urinary stents design and fabrication
Ch 33: Preventing biofilm formation and encrustation on urinary implants: (bio)coatings and tissue engineering
Ch 34: Preventing biofilm formation and encrustation on urinary implants: (bio)molecular and physical research approaches
Ch 35: Ten steps to strategic planning for the urinary stents of the future.
Ch 2: Indications, Complications and side effects of Ureteral stents
Ch 3: Indications, Complications and side effects of metallic ureteral stents
Ch 4: Urethral stents. Indications, complications and adverse effects
Ch 5: Ureteral stents. Impact on patient's quality of life.
Ch 6: Strategies to improve the quality of life of stented patients
Ch 7: Use of drugs to reduce the morbidity of ureteral stents
Ch 8: Ureteral stent designs to reduce stent-related symptoms and improve patient quality of life
Ch 9: Encrustation in urinary stents
Ch 10: Forgotten ureteral stent syndrome
Ch 11: Endourological management of encrusted ureteral stents
Ch 12: Pediatric Ureteral Stents
Ch 13: Flow dynamics in stented ureter
Ch 14: Methodology for the development and validation of new stent designs: in vitro and in vivo models
Ch 15: Methodology on clinical evaluation of urinary stents
Ch 16: A Dynamically Degradable Surface: Can We ‘Fool’ Bacteria to Delay Biofouling in Urinary Stents?
Ch 17: Biomaterials for ureteral stents: advances and future perspectives
Ch 18: Coatings for urinary stents:current state and future directions
Ch 19: Bacterial adhesion and biofilm formation: hydrodynamics effects
Ch 20: Biomaterial-associated infection: pathogenesis and prevention
Ch 21: Antibiotic-free solutions for the development of biofilm prevention coatings
Ch 22: Plasma Based Approaches for Deposition And Grafting Of Antimicrobial Agents To Polymer Surfaces
Ch 23: Antimicrobial biosurfactants towards the inhibition of biofilm formation
Ch 24: Novel antimicrobial strategies to combat biomaterial infections
Ch 25: Light-activated polymer nanocomposites doped with a new type of carbon quantum dots for antibacterial applications
Ch 26: Nanoparticles. Potential for use to prevent infections
Ch 27: Urinary tract infections and encrustation in urinary stents
Ch 28: Learning from our mistakes:Applying Vascular Stent Technologies to the Urinary Tract
Ch 29: Biodegradable urinary stents
Ch 30: New double-J stent design for preventing/reducing irritative bladder symptoms & flank pain
Ch 31: Drug eluting devices in the urinary tract
Ch 32: Methods and Materials for drug eluting urinary stents design and fabrication
Ch 33: Preventing biofilm formation and encrustation on urinary implants: (bio)coatings and tissue engineering
Ch 34: Preventing biofilm formation and encrustation on urinary implants: (bio)molecular and physical research approaches
Ch 35: Ten steps to strategic planning for the urinary stents of the future.